Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
PHSYX vs SWHFX
Shared holdings
28
PHSYX covered by SWHFX
63.03%
SWHFX covered by PHSYX
63.03%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 43 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
PHSYX (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 11.32% | |
| JOHNSON&JOHNSON | 8.89% | |
| ABBVIE INC | 5.93% | |
| Novartis AG (Registered) | 5.52% | |
| MERCK & CO | 5.32% | |
| ASTRAZENECA PLC | 5.04% | |
| UNITEDHEALTH GRP | 4.92% | |
| INTUITIVE SURGICAL INC | 3.89% | |
| THERMO FISHER SCIENTIFIC INC | 3.70% | |
| ROCHE HOLDINGS AG (GENUSSCHEINE) | 2.90% | |
| BOSTON SCIENTIFIC CORP | 2.83% | |
| GILEAD SCIENCES INC | 2.68% | |
| MCKESSON CORP | 2.62% | |
| MEDTRONIC PLC | 2.47% | |
| Sanofi SA | 2.33% | |
| VERTEX PHARMACEUTICALS INC | 2.30% | |
| CARDINAL HEALTH INC | 2.27% | |
| BRISTOL-MYERS SQUIBB CO | 2.08% | |
| CVS HEALTH CORP | 1.84% | |
| Ascendis Pharma A/S | 1.67% | |
| EDWARDS LIFESCIENCES CORP | 1.62% | |
| HCA HEALTHCARE INC | 1.52% | |
| NOVO NORDISK-B | 1.45% | |
| Putnam Short Term Investment Fund, Class P | 1.32% | |
| ALNYLAM PHARMACEUTICALS INC | 1.31% | |
| CHUGAI PHARMA CO | 1.25% | |
| HOYA CORP | 1.24% | |
| REGENERON PHARMACEUTICALS INC | 1.23% | |
| UCB SA | 1.04% | |
| ARGENX SE | 1.01% | |
| ABBOTT LABS | 0.99% | |
| BECTON DICKINSON and CO | 0.98% | |
| GSK PLC | 0.95% | |
| VAXCYTE INC | 0.88% | |
| INSMED INC | 0.84% | |
| RHYTHM PHARMACEUTICALS INC | 0.63% | |
| US ULTRA BOND CBT Sep25 | 0.43% | |
| NEWAMSTERDAM PHARMA COMPANY NV | 0.25% | |
| PRECIGEN INC | 0.22% | |
| Putnam Cash Collateral Pool LLC | 0.15% | |
| U.S. Treasury Bills | 0.12% | |
| U.S. Treasury Bills | 0.03% | |
| FX Spot Contract: EUR/USD SETTLE 2026-01-05 | 0.00% |
SWHFX (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 12.06% | |
| JOHNSON&JOHNSON | 6.82% | |
| ABBVIE INC | 5.80% | |
| MERCK & CO | 4.20% | |
| GILEAD SCIENCES INC | 4.03% | |
| STRYKER CORP | 3.95% | |
| BOSTON SCIENTIFIC CORP | 3.56% | |
| MEDTRONIC PLC | 3.33% | |
| ASTRAZENECA PLC | 3.22% | |
| Novartis AG (Registered) | 3.05% | |
| AMGEN INC | 2.74% | |
| UNITEDHEALTH GRP | 2.74% | |
| GSK PLC | 2.43% | |
| ROCHE HOLDINGS AG (GENUSSCHEINE) | 2.40% | |
| THERMO FISHER SCIENTIFIC INC | 2.30% | |
| IQVIA HOLDINGS INC | 1.48% | |
| MCKESSON CORP | 1.48% | |
| THE CIGNA GROUP | 1.46% | |
| REGENERON PHARMACEUTICALS INC | 1.29% | |
| ABBOTT LABS | 1.24% | |
| NOVO NORDISK-B | 1.21% | |
| CARDINAL HEALTH INC | 1.15% | |
| STERIS PLC | 1.14% | |
| VERTEX PHARMACEUTICALS INC | 1.11% | |
| BECTON DICKINSON and CO | 0.98% | |
| EXELIXIS INC | 0.97% | |
| RESMED INC | 0.95% | |
| HEALTHEQUITY INC | 0.94% | |
| ASTELLAS PHARMA | 0.93% | |
| METTLER-TOLEDO INTL INC | 0.92% | |
| DANAHER CORP | 0.89% | |
| HCA HEALTHCARE INC | 0.85% | |
| UCB SA | 0.79% | |
| UNITED THERAPEUTICS CORP DEL | 0.78% | |
| IPSEN | 0.73% | |
| BIOGEN INC | 0.72% | |
| PRESTIGE CONSUMER HEALTHCARE INC | 0.71% | |
| MEDPACE HOLDINGS INC | 0.71% | |
| GE HEALTHCARE TECHNOLOGIES INC WI | 0.69% | |
| ANI PHARMACEUTICALS INC | 0.68% | |
| BRISTOL-MYERS SQUIBB CO | 0.57% | |
| VERACYTE INC | 0.53% | |
| INTUITIVE SURGICAL INC | 0.53% | |
| INCYTE CORP | 0.49% | |
| Sanofi SA | 0.49% | |
| CATALYST PHARMACEUTICALS INC | 0.48% | |
| BRIGHTSPRING HEALTH SERVICES INC | 0.45% | |
| SHIONOGI & CO | 0.44% | |
| HANSOH PHARMACEU | 0.44% | |
| AGILENT TECHNOLOGIES INC | 0.41% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.